Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Other solid neoplasm 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Solid Tumors 2

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × darinaparsin × Other solid neoplasm × Clear all
NCT00509782 2012-08-01

Phase I Trial of ZIO-101 in Patients With Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Completed
47 enrolled
Other solid neoplasm

Solid Tumors

NCT00591396 2012-07-19

A Phase I Trial of ZIO-101 in Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
40 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡